Combination Therapy of an anti-cd20 Antibody afucosilado with an anti VEGF antibody

摘要

Combination Therapy of an anti-cd20 Antibody afucosilado with an anti VEGF Antibody for the treatment of cancer, particularly in combination Therapy of cancers that Express CD20 Antibody with a B - LY1 afucosilado and a Humanized anti VEGF Antibody.Claim 8: a composition comprising an Antibody B - LY1 Humanized afucosilado with an amount of fucose is 60% or less of the total amount of Oligosaccharides (Sugars) in the asn297 Antibody bevacizumab, and B20 or Series, for the treatment of cancer.